Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where remedy choices remain limited. Use the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline We're https://financefeeds.com/21x-hires-victoria-jahn-as-head-of-regulatory-affairs/